Bioinformatics analysis of the expression and clinical significance of ITGA2 gene in pancreatic adenocarcinoma
返回论文页
|更新时间:2023-04-16
|
Bioinformatics analysis of the expression and clinical significance of ITGA2 gene in pancreatic adenocarcinoma
Journal of Chongqing Medical UniversityVol. 47, Issue 12, Pages: 1485-1489(2022)
作者机构:
山西医科大学第一临床医学院,太原,030001
作者简介:
基金信息:
DOI:
CLC:R735.7
Published:2022,
扫 描 看 全 文
Jia Yu. Bioinformatics analysis of the expression and clinical significance of ITGA2 gene in pancreatic adenocarcinoma. [J]. Journal of Chongqing Medical University 47(12):1485-1489(2022)
DOI:
Jia Yu. Bioinformatics analysis of the expression and clinical significance of ITGA2 gene in pancreatic adenocarcinoma. [J]. Journal of Chongqing Medical University 47(12):1485-1489(2022)DOI:
Bioinformatics analysis of the expression and clinical significance of ITGA2 gene in pancreatic adenocarcinoma
Objective: To study the expression of ITGA2 (integrin alpha-2) in pancreatic adenocarcinoma
the relationship between expression and prognosis
the relationship between expression and clinicopathological characteristics
and to further predict the biological function of ITGA2. Methods: The GEPIA online tool was used to analyze the expression difference of ITGA2 gene in pancreatic adenocarcinoma tissues and normal tissues in The Cancer Genome Atlas (TCGA) database
and the relationship between the expression level and survival prognosis was analyzed retrospectively. The LinkedOmics database was used to screen the list of co-expressed genes of ITGA2 in pancreatic adenocarcinoma
and the biological functions were analyzed in the WebGestalt database. The clinical information and ITGA2 expression data of pancreatic adenocarcinoma patients was downloaded
the relationship between ITGA2 expression and clinicopathological characteristics was analyzed
and the risk factors that would affect survival and prognosis of pancreatic adenocarcinoma was studied. Results: ITGA2 was significantly highly expressed in pancreatic adenocarcinoma tissues (P<0.05). Compared with patients with low expression
the overall survival of pancreatic adenocarcinoma patients with high ITGA2 expression (log-rank P=0.002) and disease-free survival (log-rank P=0.004) significantly reduced. Using LinkedOmics
278 genes co-expressed with ITGA2 were identified. Gene Ontology (GO) analysis showed that these genes were mainly involved in biological processes such as cell adhesion
intercellular junction composition
and cytoskeleton formation; Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed significant enrichment in focal adhesions
adhesion junctions
tight junctions
regulation of actin cytoskeleton
tumor proteoglycans and other pathways. The expression level of ITGA2 was significantly correlated with tumor stage (χ2=6.380
P=0.036)
tumor size or invasion range (χ2=5.214
P=0.022)
and degree of tumor differentiation (χ2=11.998
P=0.002). Cox regression analysis showed that the expression level of ITGA2 was an independent risk factor affecting the prognosis of patients with pancreatic cancer (HR=1.888
95%CI=1.021-3.490
P=0.043). Conclusion: ITGA2 gene is closely related to the occurrence and development of pancreatic adenocarcinoma
which can be used as a clinical marker to determine the prognosis of pancreatic adenocarcinoma and has the potential to become a tumor treatment target.
Advances in research on the relationship between p53 gene and female reproduction
Knock-down RBX1 inhibits the proliferation,migration,and invasion of pancreatic cancer cells and promotes cell apoptosis by down-regulating PHF5A
Survival analysis of patients receiving antiretroviral treatment in integrated HIV/AIDS prevention and treatment demonstration zone of Chongqing,China,2016-2021
Evaluation of postoperative radiotherapy in the treatment of supraglottic laryngeal squamous cell carcinoma
Expression of Rce1 in bladder cancer and its influence on the apoptosis of T24 cells
Related Author
Li Luhao
Wang Qingyi
Tu Xuxu
Zhu Hui
Jiang Bei
Chang Zhuo
Zhang Jing
Yan Youyou
Related Institution
School of Basic Medical Sciences,Heilongjiang University of Chinese Medicine
Second Clinical Medical School,Heilongjiang University of Chinese Medicine
Graduate School,Heilongjiang University of Chinese Medicine
Translational Medicine Research Center, Affiliated Hangzhou First People’s Hospital,Zhejiang University School of Medicine
Department of Gastroenterology, Affiliated Hangzhou First People’s Hospital,Zhejiang University School of Medicine